Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 24, 2019 - Issue 10
Submit an article Journal homepage
133
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation

Aiping WangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China; Correspondence[email protected]
View further author information
,
Xiuju YanSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China; View further author information
,
Rongcai LiangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China; Correspondence[email protected]
View further author information
,
Linlin WangState Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, Shandong Province, People’s Republic of ChinaView further author information
,
Liuxiang ChuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China; View further author information
,
Kaoxiang SunSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China; View further author information
&
Fenghua FuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China; View further author information
 show all
Pages 1229-1235 | Received 27 Dec 2018, Accepted 30 Jul 2019, Published online: 20 Aug 2019

References

  • Ahn J, Park E, Lee H, Lee K, Na D. 2011. Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems. AAPS Pharm Sci Tech. 12(4):1220–1226.
  • Cai Y, Wei L, Ma L, Huang X, Tao A, Liu Z, Yuan W. 2013. Long-acting preparations of exenatide. Drug Des Dev Ther. 7:963–970.
  • Chae S, Choi Y, Son S, Jung Y, Lee D, Lee K. 2010a. The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics. J Control Release. 144(1):10–16.
  • Chae S, Jin C, Shin J, Son S, Kim T, Lee S, Youn Y, Byun Y, Lee M, Lee K. 2010b. Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs. J Control Release. 142(2):206–213.
  • DeYoung M, MacConell L, Sarin V, Trautmann M, Herbert P. 2011. Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. Diabetes Technol Ther. 13(11):1145–1154.
  • Drucker D, Nauck M. 2006. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet. 368(9548):1696–1705.
  • Hu M, Zhang Y, Xiang N, Zhong Y, Gong T, Zhang Z, Fu Y. 2016. Long-acting phospholipid gel of exenatide for long-term therapy of type II diabetes. Pharm Res. 33(6):1318–1326.
  • Kulasa K. 2011. The current status of exenatide once weekly. Clin Med Insights Ther. 3:CMT.S3083.
  • Kuranov S, Tsypysheva I, Khvostov M, Zainullin L, Borisevich S, Vakhitova Y, Luzina O, Salakhutdinov N. 2018. Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus. Bioorg Med Chem. 26(15):4402–4409.
  • Lee J, Ryu J, Kim S, Park M, Kim S, Shin Y, Sohn J, Kim H, Park Z, Seong J, Kim J. 2018. Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility. Biochem Pharmacol. 151:59–68.
  • Liang R, Li X, Zhang R, Shi Y, Wang A, Chen D, Sun K, Liu W, Li Y. 2014. Acylation of exenatide by glycolic acid and its anti-diabetic activities in db/db mice. Pharm Res. 31(8):1958–1966.
  • Liang R, Zhang R, Li X, Wang A, Chen D, Sun K, Liu W, Li Y. 2013. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer. Eur J Pharm Sci. 50(3–4):502–510.
  • Murty S, Thanoo B, Wei Q, DeLuca P. 2005. Impurity formation studies with peptide-loaded polymeric microspheres part I. In vivo evaluation. Int J Pharm. 297(1–2):50–61.
  • Painter N, Morello C, Singh R, McBane S. 2013. An evidence-based and practical approach to using Bydureon™ in patients with type 2 diabetes. J Am Board Fam Med. 26(2):203–210.
  • Sun C, Trevaskis J, Jodka C, Neravetla S, Griffin P, Xu K, Wang Y, Parkes D, Forood B, Ghosh S. 2013. Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics. J Med Chem. 56(22):9328–9341.
  • Syed Y, McCormack P. 2015. Exenatide extended-release: an updated review of its use in type 2 diabetes mellitus. Drugs. 75(10):1141–1152.
  • Wang P, Zhuo X, Chu W, Tang X. 2017. Exenatide-loaded microsphere/thermosensitive hydrogel long-acting delivery system with high drug bioactivity. Int J Pharm. 528(1–2):62–75.
  • Zhang Y, Schwendeman S. 2012. Minimizing acylation of peptides in PLGA microspheres. J Control Release. 162(1):119–126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.